Inovio Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.16

-0.05 (-4.13%)

As of Oct 3, 2:29 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +1,590.5% upside

Low Target $14.26

Average Target $19.61

High Target $29.32

Current Price $1.16

Current
$1.16

Target
$19.61

$14.26 $19.61 avg $29.32

Scenario Analysis

Bear Case

$14.26

1,129.3%

Low target

Base Case

$19.61

+1,590.5%

Avg target

Bull Case

$29.32

+2,427.6%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.72

-57.4% from high

52-Week Low

$0.56

+106.0% from low

Target vs 52W High

$19.61

+621.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%